Infection Risk During Rituximab Therapy in Multiple Sclerosis: Effect of Dosing Interval and Age. Pihl-Jensen G, Selle M L, Aarseth J H, Myhr K-M, Torkildsen Ø, Nakken O, Holmøy T Neurol Clin Pract. 2026 Dec; 16(6):e200664. PMID: 42854181. Abstract CommentRecommendBookmarkWatch
